TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease

Chinese herbs can facilitate sputum culture conversion, promote lesion absorption, and enhance clinical symptoms and quality of life for patients with Mycobacterium abscessus pulmonary disease (MAB-PD). The investigators aimed to evaluate the efficacy of Chinese herbs as adjunct therapy to improve cure rates or reduce recurrence rates during the continuation phase of MAB-PD treatment.

NCT Number	NCT07295938
Lead Sponsor	Shanghai University of Traditional Chinese Medicine Collaborators: Shanghai Pulmonary Hospital, Shanghai, China, Anhui Chest Hospital, Guangzhou Chest Hospital., Jiangxi Chest Hospital, Beijing Chest Hospital, China-Japan Friendship Hospital, Huashan Hospital
Conditions	Mycobacterium Abscessus Pulmonary Disease
Enrollment	352 participants
Start Date	2025-09-08
Primary Completion	2028-11 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2025-12-22